Appen Reports 1H23 Results and Outlines FY2023 Outlook Amidst Challenging Environment

Aug 28, 2023

Appen Limited (ASX: APX) has unveiled its 1H23 financial results and provided insights into its outlook for the fiscal year 2023. The company's 1H FY23 results were influenced by complex external operational and macroeconomic conditions, as previously indicated in its May 10, 2023, trading update.

Key 1H23 financial highlights include:

  • Group revenue of AU$138.9 million, marking a 24.0% decrease, primarily due to reduced contribution from Global Services and New Markets.
  • Underlying EBITDA (before FX) stood at (AU$15.7) million compared to AU$9.6 million in 1H FY22, primarily due to lower revenue and gross margin.
  • Underlying net loss after tax reached (AU$34.2) million, compared to a loss of (AU$3.8) million.
  • Cash balance of AU$55.2 million by June 30, 2023, with no debt.
  • No dividend issued to ensure prudent allocation of capital.

Despite these challenges, Appen's CEO & President, Armughan Ahmad, highlighted the company's strategic focus on operational efficiency, generative AI products, sales strategies, ecosystem partnerships, and AI for social good. Appen has also embarked on a significant cost reduction initiative, with AU$28.9 million (63% of the target) achieved by mid-year. The company aims to exit FY23 as an underlying EBITDA and cash EBITDA positive entity, while focusing on high-potential areas for growth.

Appen remains optimistic about its position in the AI industry, with a growing demand for generative AI products and collaborations with leading tech firms. The company's strategic realignment and strong AI capabilities position it for future growth.

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com